mice with transgenic mice expressing Cre controlled by a cglutamyltranspeptidase promoter. These mutants developed cysts in both proximal and distal nephron segments and survived for about 4 weeks. Somatic loss of heterozygosity was shown in a reporter mouse strain to cause cystogenesis. Some cysts in young mice are positive for multiple tubular markers and a mesenchymal marker, suggesting a delay in tubular epithelial differentiation. A higher cell proliferation rate was observed in distal nephron segments probably accounting for the faster growth rate of distal cysts. Although we observed an overall increase in apoptosis in cystic kidneys, there was no difference between proximal or distal nephron segments. We also found increased cyclic AMP, aquaporin 2 and vasopressin type 2 receptor mRNA levels, and apical membrane translocation of aquaporin 2 in cystic kidneys, all of which may contribute to the differential cyst growth rate observed. The accelerated polycystic kidney phenotype of these mice provides an excellent model for studying molecular pathways of cystogenesis and to test therapeutic strategies. Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder, with an average occurrence of 1:500-1:1000 people and accounting for 45% of patients with end-stage renal failure in Europe and the United States. 1 ADPKD is characterized by focal formation of multiple cysts in the kidneys, in the liver in B50% of cases, and much less frequently in the pancreas. Cardiovascular abnormalities, including hypertension, mitral valve prolapse, and intracranial aneurysms, are also often recognized. ADPKD is caused by mutations in PKD1 and PKD2 genes encoding polycystin-1 and 2 (PC1 and PC2). PC1 and PC2 function as a mechanosensitive receptor-channel protein complex and mediate G-protein and Ca 2 þ signaling. 2, 3 Every cell in an ADPKD patient carries an inherited mutation in either the PKD1 or PKD2 gene, yet focal cysts form in only B5% of nephrons. Reeders 4 proposed a 'twohit' hypothesis to explain the focal nature of cyst development: a germline mutation in one of the two copies ('alleles') of, for example, PKD1 in a given cell is not sufficient to alter the phenotype of that cell and initiate cyst formation because the second allele is functioning normally. Cystogenesis occurs when a somatic mutation knocks out the 'normal' allele so that one allele has a germline mutation ('first hit'), the other has a somatic mutation ('second hit'), neither allele is functional, and no PC function remains. A cyst then forms through proliferation of the cell that has received two 'hits. ' The hypothesis predicts that the number of cysts will increase during life as the somatic or second hits accumulate. This hypothesis has since received support from studies in renal cysts 5 and liver cysts 6 using human tissues with ADPKD. Using gene targeting, a powerful tool for studying gene function in vivo, inactivation of mouse Pkd1 and Pkd2, including Pkd1 del34 , 7 Pkd1 del43-45 , 8 Pkd1 null , 9 Pkd1
del17-21bgeo , 10 and Pkd2, 11 resulted in similar phenotypes. In homozygotes, kidney development proceeds normally until embryonic day 15.5, at which time point cystic dilatation of renal tubules is evident, as is cystic degeneration in the pancreas, 7, 9 which is consistent with the 'two-hit' hypothesis. All homozygous mice develop polyhydramnios and hydrops fetalis. 7, 9 Whereas defects in skeletal development have been described for Pkd1 mutants, 9, 10 Pkd2-targeted mice develop laterality defects. 12 Mice with a heterozygous mutation of Pkd1, however, only develop scattered renal and hepatic cysts late in life. 13 The slow rate of cyst development in Pkd1 heterozygotes was hypothesized to be the result of the slow development of somatic second hits in mice. 13 Conventional gene targeting has provided us valuable clues about the role of PC1 and PC2 in development; [7] [8] [9] [10] [11] however, it has been less effective in elucidating the physiological or pathophysiological processes that occur later in life for the following reasons. First, inactivation of a developmentally important gene, such as Pkd1, resulted in perinatal lethality, excluding the possibility of functional analysis in adult life. Second, conventional gene-targeting technology is unable to introduce mutations in a time-and location-specific manner.
The Cre-loxP site-specific recombination system has been used successfully to produce mice with tissue-and timespecific deletions.
14 By crossing 'floxed' mice with transgenic mice expressing the Cre recombinase in the desired timeand/or tissue-specific manner, one can achieve conditional gene inactivation. This approach was used recently to develop a conditional model in which somatic Pkd1 inactivation was under the control of MMTV.Cre. 15 Although mice were created successfully, only scattered cysts were observed in mice at 20 weeks of age. The lack of a polycystic kidney phenotype and the length of time needed to develop scattered cysts limit the usefulness of this model for phenotypic and experimental studies of ADPKD.
In this study, we developed two new Pkd1-knockout mouse models simultaneously with using Cre-loxP technology. These mice develop striking polycystic kidney pathology. Disruption of the Pkd1 gene in a time-and tissue-specific manner yielded direct evidence supporting the two-hit hypothesis.
RESULTS

Generation of the Pkd1 conditional knockout mouse
A Pkd1 conditional construct was designed to study the effects of loss of PC function after birth. A loxP-flanked neomycin selection cassette was inserted into the EcoRI site located 1.2 kb upstream of exon 2, and a third loxP site was placed in intron 6 ( Figure 1a) . Homologous recombinants were identified by Southern blotting using a 5 0 probe. Two independently targeted embryonic stem cell clones were injected into C57BL/6J blastocysts. The resulting chimeric mice, with 490% of the agouti coat, were crossed with C57BL/6 and BALB/c mice to produce F1 progeny with germline transmission.
The offspring with germline transmission were crossed with mice carrying a germline Cre transgene (Prm.Cre). The Cre recombinase targets random combinations of any of the three available loxP sites and results in four possible recombinations, two of which are desirable events ( Figure  1b) . One leads to complete deletion of the region between the two outlying loxP sites, creating a conventional knockout, dubbed 'Pkd1 del2 -6 '. The other leads to removal of only the neomycin cassette, which creates what is commonly called a 'floxed' allele. The latter is used for generating conditional knockouts by crossing with a transgenic mouse expressing a tissue-specific Cre recombinase.
The design of the Pkd1 conditional targeted construct was expected to result in deletion of exons 2 through 6, which is an in-frame deletion. Reverse transcriptase-polymerase chain reaction on RNA isolated from kidneys with primers specific for exons 1(KO-F), 2 (F27), 5(R37), 10 (R104/F201), and 11(R201) (Figure 1a , 'floxed' allele) showed that the Pkd1 transcript present in our conventional mutants lacks not only exons 2 through 6, but also exon 7 ( Figure 1c ). This alternative splicing event resulted in a transcript with a stop codon at the beginning of exon 8 ( Figure 1c) .
To investigate whether these mutant transcripts produced stable products, we examined the expression levels of the Pkd1 protein in kidney lysates from Pkd1 del2-6 homozygotes and heterozygotes, and compared them with that of wildtype littermates using a monoclonal antibody, 7e12, directed against the N-terminal region of PC1. A band of B460 kDa was detected in both the wild-type and heterozygous newborn kidneys, but it was absent in homozygous Pkd1 del2-6 mutants (Figure 1d , left). PC2 appears to be expressed normally, although protein levels in the Pkd1 del2-6 homozygotes appeared to be slightly decreased (Figure 1d , right). PC1 and PC2 directly interact through the putative coiledcoil domains in their C-termini. 16 It has been reported that the rate of cell proliferation increases in ADPKD kidney epithelia, which may be a result of decrease of p21 in polycystic kidneys. 17 Similar to our Pkd1 null/null mutants, 18 we found an decrease in the expression of cyclin-dependent kinase inhibitor p21 in the kidneys of newborn Pkd1 del2-6/del2-6 mice, as compared with that in their respective wild-type littermates (Figure 1e ). However, p27 expression in homozygous Pkd1 del2-6 kidneys was not altered significantly ( Figure 1e ).
Rapid progression of kidney cysts in homozygous
To investigate whether deletion of exons 2-6 of the Pkd1 gene would result in functional inactivation of PC1, we intercrossed Pkd1 del2-6 mice to produce homozygous Pkd1 del2-6/del2-6 offspring. From our previous studies, we know that homozygous inactivation of Pkd1 results in embryonic lethality; we therefore expected that Pkd1 del2-6/del2-6 offspring were unlikely to be viable. To our surprise, B50% of the homozygous Pkd1 del2-6/del2-6 mice survived to birth ( Table 1 ). The survival rate for mice homozygous for Pkd1 del2-6 was much higher than that of mice homozygous for the previously described Pkd1 null mutants. 9 Virtually all homozygous Pkd1 del2-6 pups died on the day of birth, whereas homozygous Pkd1 null mutants died as early as E13.5, with a peak between E14.5 and E16.5, 9 although in very rare cases, they survived longer. (Table 2) were set up, and 25 Pkd1 del2-6 homozygotes were examined histologically for renal cystic lesions. At E15 and E17, the cyst size in Pkd1 del2-6 kidneys was comparable to that of Pkd1 null kidneys at the respective stages. The homozygous Pkd1 del2-6 pups surviving to birth exhibited the same phenotype as documented previously for other Pkd1 homozygous mutations, with polyhydramnios and systemic edema. 7, 9 Onset of the cystic phenotype in Pkd1 del2-6 homozygous embryos occurred at the same stage (E15.5) as reported for the Pkd1 del34 and Pkd1 null mutants 7, 9 (data not shown).
Somatic inactivation of the normal allele of Pkd1 and the two-hit hypothesis To achieve conditional inactivation of Pkd1 in kidney, we bred our Pkd1 flox mice with a transgenic mouse in which Cre expression was driven by a promoter fragment of gglutamyltranspeptidase (gGt). gGt is expressed and regulated in a tissue-specific manner, and is known to be present in bile ducts, kidney, intestine, and other organs involved in secretion. The gGt.Cre transgene is known to be expressed in the kidney proximal tubule. 19 To evaluate the effects of the somatic inactivation of Pkd1 and the role of compound heterozygous mutations on cyst formation, we crossed gGt.Cre:Pkd1 were observed for live-born progeny of all possible genotypes, indicating that no embryos in any group died during embryogenesis. Although no cystic phenotype was observed in heterozygous mice with gGt.Cre: Figure S1e , f, h, and i), which selectively stain the proximal tubule, the collecting tubule/duct segments, or the thick ascending limbs of Henle's loop, to identify the tubular origin of a particular cyst. We found that cysts in gGt-Cre:Pkd1 flox/flox kidneys can originate from either proximal or distal tubular segments, with the larger cysts being mainly distal rather than proximal in origin ( Figure 4c ; Figure S1a-i). These findings expand upon the observation that gGt.Cre is expressed in mouse kidney cortex, since specific tubular segments were not characterized in that study. 19 To determine whether collecting tubule cysts were secondary to proximal tubule cysts, or were the result of Cre expression in these tubules, we generated gGt.Cre:DsRed:Pkd1 fragment is active in both proximal and distal nephron segments.
Distal tubular cysts progress at a faster rate than cysts of proximal tubule origin
Most of the larger cysts were located in the more medullary regions of the gGt.Cre:Pkd1 flox/flox kidneys. We therefore investigated the tubular origins of these cysts in relationship to their size and progression rate. We co-stained kidney sections of 16 different animals ranging in age from 3 to 26 days for proximal (LTA) and distal (collecting tubule/ducts) (DBA) tubular markers using directly labeled lectins to avoid the cross-reactions of secondary detection methods. Using fluorescence microscopy, we determined the number and origin of the cysts in at least three fields on two separate sections per animal. The relative cyst sizes were subsequently measured with Image-Pro Plus software. The rate of cyst enlargement in relationship with their origin (either proximal or distal) was documented and compared. Interestingly, the size of distal tubule cysts increased much more than the proximal tubule cysts (Figure 6a ). Furthermore, after 12-15 days of age, the proximal tubule cysts did not increase in size and either regressed or completely disappeared, leaving mostly large cysts of distal tubule origin, which greatly increased the DBA:LTA cyst size ratio to B70-fold (Figure 6b) . A decrease in the total number of cysts was also noted, whereas the number of cysts of different origin per observed field remained largely constant, with an equal number of cysts expressing proximal or distal tubule markers. This decrease in the total number of cysts, combined with an overall increase in kidney volume, would thus account for the increase in the size of the individual distal tubular cysts (Figure 6c ). Additionally, in animals younger than 12 days of age, up to 20% of cysts double labeled for DBA and LTA (Figure 6d) . In older animals, however, no cysts expressed more than one marker.
The role of apoptosis and cell proliferation in cyst growth
To determine the role of apoptosis in the differential growth rates of cysts, we performed terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining on kidney sections from both cystic and control mice at 3, 5, 7, 13, 15, 23, and 26 days of age. At all time points investigated, normal controls ( Figure S2a-c) showed little or no evidence of apoptosis, whereas many TUNEL-positive cells could be observed in their cystic littermates (Figure S2d-f) .
However, no differences were observed between cysts in cortex or medulla of the kidney.
Since TUNEL staining detects breaks or 'nicks' in doublestranded DNA that can arise from sources other than apoptosis, we used a complementary assay for apoptosis, by detecting the cleavage of caspase 3. We co-stained kidney sections from 2-day-old cystic mice (Figure 7a To investigate the contribution of cell proliferation in the differential growth rates of cysts, we used kidney sections from 2-day-old cystic mice (Figure 8a-f) and their healthy littermates (Figure 8g-l) , and co-stained for proliferating-cell nuclear antigen with either LTA (Figure 8a-c, g-i) or DBA (Figure 8d-f, j-l) . We observed high levels of proliferation in the nephrogenic zone and outer medulla, where elongation of the Henle's loop occurs, 20 and lower levels of proliferation in 
cAMP and cystogenesis
Changes in intracellular cAMP level could lead to changes in transcription and protein expression of cAMP-responsive proteins such as aquaporin 2 (AQP2) and the vasopressin V2 receptor (V2R). Moreover, AQP2 is known to translocate from the sub-apical domain to the apical membrane in response to increase in cAMP level. Therefore, we co-stained kidney sections from cystic mice with AQP2 and LTA ( Figure  9a-c) , or DBA (Figure 9d-f) . Whereas AQP2 was located intracellularly in normal-looking tubules (Figure 9b and c, arrowhead), it was found in the apical membrane of large DBA-positive cysts (Figure 9b and c, arrows) . No AQP2 signal was detected in LTA-positive cysts (Figure 9a-c,  asterisk) . We also measured cAMP levels in kidneys from both cystic animals and wild-type littermates, which revealed 20-fold increase in cAMP levels in cystic kidneys when compared with those in wild-type kidneys (Figure 9g ). Using real-time PCR, we found a fivefold increase for AQP2, and a sevenfold increase for V2R at the mRNA expression level in cystic kidneys when compared with normal controls (Figure  9h and i) .
DISCUSSION
In-frame deletion of Pkd1 results in a null allele
In this study, we report the creation of a new conventional (Pkd1 del2-6 ) and conditional (Pkd1 flox ) Pkd1-knockout mouse model. The design of the targeting strategy allowed us to create an in-frame deletion in the Pkd1 gene and to study the effects of PC1 lacking the leucine-rich repeat, the WSC homology domain, the first PKD domain, and the c-type lectin-binding motif in the extracellular domain. It was interesting to discover that an alternative splicing event in the mutant transcript of the Pkd1 del2-6 mice resulted in an mRNA lacking exons 2-7 and a subsequent frame shift leading to a stop codon early in exon 8, thus effectively creating a null allele. This finding is of clinical significance, suggesting 'in-frame deletions' may function as inactivation mutations. The PC1 protein was absent in the Pkd1 del2-6 mouse kidneys, which is consistent with the mRNA data.
Although both new Pkd1 del2-6 and the previously published Pkd1 null9 mutations result in a null effect and the absence of PC1 protein, the main difference between them is the removal of the neo cassette in the Pkd1 del2-6 -mutant allele. One striking phenotypic difference between homozygous Pkd1 del2-6 and Pkd1 null mice that we observed was their survival rate. Approximately 55% of the Pkd1 del2-6 homozygotes survived to term, although most died within hours after birth, whereas the Pkd1 null homozygotes rarely survived beyond E18.5, as reported previously. 9 Only four of 143 Pkd1 null homozygotes in the C57/B6 genetic background survived to term, but died immediately after birth. Most Pkd1 null homozygous embryos with a C57BL/6-129 mixed background, identical to Pkd1
, succumbed by E17.5. 
Pkd1
del2-6 and Pkd1 null kidneys both appear to be phenotypically normal until E15.5, when cysts first arise. Aside from the renal phenotype, Pkd1 del2-6 mice develop pancreatic cystic disease, as well as gross edema, as reported previously for Pkd1 null mice. 9 However, the observed phenotype in Pkd1 del2-6 seems to be slightly milder than that observed in Pkd1 null mice likely contributing to the increased survival observed in the former. The insertion of a neomycin resistance cassette in exon 4 of the Pkd1 null mutants may have an impact on the genomic structure different from the deletion of exons 2-6 in the Pkd1 del2-6 mutants, which may contribute to the increased survival of Pkd1 del2-6
. We did not observe any abnormality in the left-right body axis determination in all 41 Pkd1 del2-6 homozygous embryos examined (out of a total of 323 pups in 46 litters). In Pkd1 del2-6/ þ mice 8-21 months old, we observed sporadic macroscopic liver and kidney cysts.
A new ADPKD mouse model by somatic inactivation of the normal Pkd1 allele In 1992, Reeders 4 proposed a two-hit hypothesis as the mechanism of cystogenesis for sporadic distribution of cysts observed in ADPKD, and experimental evidence in human tissues has supported this notion. 5, 6 To study the effect of somatic inactivation of the Pkd1 allele in an animal heterozygous for a Pkd1 null mutation, we generated a compound heterozygous Pkd1-knockout mouse, gGt.Cre:Pkd1 null/flox . Characterization of this model clearly demonstrated that somatic inactivation of the second (normal) Pkd1 allele causes cystogenesis, in accordance with the two-hit hypothesis. The massive cystogenesis in gGt.Cre:Pkd1 null/flox mice, as compared with the very mild phenotype in Pkd1 del2-6/ þ mice and other reported heterozygous phenotype in Pkd1 mutants, can be attributed to the much higher rate of second hits due to the presence of a Cre transgene and the inactivation of the second Pkd1 allele due to the recombination of the loxP sites rather than awaiting spontaneous events. Recently, Piontek et al. 15 reported the creation of a conditional Pkd1-knockout model in which somatic inactivation of Pkd1 was achieved by Cre expression under an mouse mammary tumor virus (MMTV) promoter. However, cysts developed and progressed very slowly. Very few renal cysts formed in mice older than 2.5 months, 15 probably because of a mosaic low level of expression of Cre recombinase. The very sporadic cyst formation and slow progression, although mimicking the ADPKD phenotype, makes this model less desirable for the study of cystogenesis. In the gGt-driven model discussed in this study, we report massive and rapidly progressing cystogenesis in postnatal animals, which would be a very useful tool for further studies of polycystin function and ADPKD.
A notable observation during characterization of the gGt.Cre:Pkd1 null/flox phenotype was that the larger cysts appeared to be primarily located in the renal medulla, indicating a more distal origin. gGt.Cre was previously reported to be expressed in renal cortex, which mostly consists of proximal tubules. 19 This study identified a broader expression pattern for gGt.Cre, which raises several new questions. Is gGt.Cre expressed developmentally in common tubule progenitor cells that later develop into distinct tubular segments? Timed pregnancies using DsRed-reporter mice showed no evidence of gGt.Cre expression at E15.5 (data not shown), suggesting this is not a likely possibility. A more favorable explanation is that gGt.Cre is expressed in distal tubule segments at a low level as only four Cre molecules are necessary for the excision of the floxed fragment. 21, 22 The use of DsRedreporter mice in conjunction with DBA, a collecting-duct marker, revealed the presence of Cre recombinase in distal segment derived cyst-lining epithelia, which indicates that the gGt promoter fragment was indeed active in distal nephron segments. Staining with other tubular markers, such as THP, further confirmed this observation, suggesting that this model is of close resemblance to human ADPKD in which cysts are of both distal and proximal tubule origin. 23 Another interesting observation is that some cysts are positive for THP, DBA, and LTA markers in gGt.Cre: Pkd1 flox/flox animals under postnatal 2 weeks of age. In wildtype animals, this is only observed in embryonic kidneys. Because expression of multiple tubular segmental markers was not seen in older gGt.Cre:Pkd1 flox/flox animals, these findings suggest a delay in the maturation of tubular epithelial cells in polycystic kidneys. Expression of the mesenchymal marker smooth-muscle actin in DBA-and THP-positive cysts supports this hypothesis ( Figure S1 ).
Potential mechanisms for a faster growth rate in cysts derived from distal nephron segments Cysts of distal tubule origin always appeared to be larger than those derived from proximal tubules, which is similar to what is observed in end-stage ADPKD kidneys in humans. We therefore investigated the possible relationship between cyst progression and tubular origins in time. Surprisingly, we found that at early stages (p4 days), distal tubule cysts are, on average, already four times larger than their proximal counterparts. At late stages, the size ratio between DBA:LTA cysts increased up to 70-fold. Is the faster growth rate of distal cysts due to an increase in apoptosis in proximal versus distal nephron segments, or a higher rate of cell proliferation in the distal tubules? Although we observed enhanced apoptosis in gGt.Cre:Pkd1 flox/flox mouse kidneys, when compared with controls, by TUNEL and Casp3 staining, which label fragmented DNA in apoptotic cells and cells committed to apoptosis, respectively, we did not see any difference in cell death rate between cysts of proximal or distal tubule origin. In contrast, by proliferating-cell nuclear antigen staining, we observed a higher rate of proliferation in distal nephron segments when compared with proximal segments, which suggests that increased proliferation contributes to the more rapid growth of distal cysts in gGt.Cre:Pkd1 flox/flox mouse kidneys.
It is interesting to note that distal segments (positive for DBA) and medullary nephron segments seem to have a higher proliferation rate than proximal tubules in normal early postnatal kidneys (Figure 8) . Moreover, the size of proximal tubule cysts ceased to increase from postnatal day 12-15 ( Figure 6 ), which coincides with the completion of development and maturation of the normal kidney. After this time, the proximal tubule cysts were significantly smaller, which may be an indication of a non-essential role of PC1 in this nephron segment from this stage onwards. This notion is supported by our previous finding that expression of PC1 in the kidney decreases drastically after postnatal 2 weeks. 24 Particularly, proximal tubule expression of PC1 became nearly undetectable in mature kidneys. 25 In the context of the 'flow hypothesis' , microvilli have been proposed to act as flow sensors in the proximal tubules, 26 which could compensate for the loss of Pkd1 as a flow sensor. 2 The distal tubules lack this ameliorating system, indicating that Pkd1 might have a critical role in the maintenance of tubule diameter in distal tubules. Alternatively, the interstitial spaces adjacent to distal tubules might be more prone to alteration or injury than those adjacent to proximal tubules. 27 Increased intracellular cAMP level has been seen in human end-stage ADPKD kidneys and may play an important role in cyst progression. [28] [29] [30] [31] [32] Since camp-responsive proteins, such as V2R and AQP2, are exclusively present in the distal segments of the kidney and increased water secretion could contribute to the faster growth rate of distal cysts. Therefore, we determined the localization of AQP2 in gGt.Cre:Pkd1 flox/flox mutants. As expected, AQP2 translocated to the apical membrane in distal cysts labeled by DBA, although remaining in its intracellular location in normal-looking tubules as shown in Figure 9 . We also determined the mRNA expression levels in cystic kidneys for AQP2 and V2R, and observed a 5-and 7-fold increase, respectively. Direct measurements of cellular cAMP levels in gGt.Cre:Pkd1 flox/flox and their normal littermates detected a 420-fold increase in cystic kidneys, thus providing the first conclusive evidence for an increase of cAMP in a Pkd1-disease model and its potential contribution to cyst enlargement.
In summary, the rapidly progressing polycystic kidney phenotype in our gGt.Cre:Pkd1 null/flox and gGt.Cre: Pkd1 flox/flox mutants, with its massive cystogenesis at an early age, but without negative effects on embryonic development, provides us with an excellent animal model for studies of pathogenesis and intervention of ADPKD.
MATERIALS AND METHODS
Generation of the Pkd1-targeting construct and chimeric mice A neomycin selection cassette flanked by two loxP sites was inserted into the EcoRI site, located 1.2 kb upstream of exon 2. A third loxP site was inserted into intron 6. All three loxP sites in the targeting vector are in a direct repeat configuration. Chimeric mice were generated by transfecting embryonic stem cells (E14, 129/sv background) with the targeting vector, and homologous recombinants were identified by PCR and Southern blot analysis using a 5 0 probe, consisting of a 1-kb PCR fragment located B1 kb upstream of the AvrII restriction site between exon 1 and 2 ( Figure 1a , probe A). Two independently targeted embryonic stem cell clones were injected into C57BL/6J blastocysts to generate chimeric mice. Chimeric mice were identified by contribution of the embryonic stem cells to coat color (agouti) and were bred with wild-type C57BL/6 mice to demonstrate germline transmission. DsRed mice (STOCK Tg(ACTB-DsRed.MST)1Nagy/J) were obtained from Jackson Laboratories (Bar Harbor, ME, USA).
Primers used
Recombination PCR was performed with the following primers: exon 1-forward (KO-F): cgagtctgcgcatcc; exon 9-reverse (R104): caggctcttcaagcttctgg; exon 2-forward (F27): cttcagacgctggacatag; exon5-reverse, (R37): ttgcttctacttgcacctctg; exon 10-forward (F201): tgtgtgcctgaggaactctg; exon 11-reverse (R201): ccaggggacactg taggaga; 'Flox' PCR was performed with the following primers: LoxP-forward (mPKD1loxpin6): acattatacgaagttatcatatgcttg; WTforward (mPKD1in6Spe2): gtcctgctgacaggactagttctt; intron 7-reverse (mPKD1WTR1): cccctctcatcttgtttcctc; Cre-PCR was performed with the following primers: gGT.Cre-forward (PST-N10-F): cttctccagtcc ccctctgttgttt; gGT.Cre-reverse (PST-N10-R): ccgcgcgcctgaagatatagaa.
(Reverse transcriptase-)PCR conditions Total RNA was harvested from kidney tissues using Trizol TM (Invitrogen, Carlsbad, CA, USA) according to the supplier's protocol. RNA quality and concentration were assayed using agarose gel electrophoresis and UV spectrophotometry ( A260 / A280 ). A 5-mg weight of total RNA was reverse transcribed using Superscript TM II reverse transcriptase (Invitrogen) in the presence of RNAseOUT Real-time PCR Samples were prepared using the Quantitect SYBR green kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol and semi-quantitative real-time PCR for AQP2 and V2R was performed with a Lightcycler 1 (Roche, Nutley, NJ, USA) with glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as internal control. The following primer sets for mouse Aqp2 (GenBank NM009699), V2R (GenBank NM019404), and Gapdh (GenBank M32599) were designed with Vector NTI advance software (Invitrogen) using identical criteria: Aqp2: 5 0 -ATGTGGGAA CTCCGGTCCAT; 3 0 -CAATCTGGAGCACAGAGGGTG; V2R: 5 0 -AT GATCCTGGTGTCTACCACGT; 3 0 -ACTAACAGCGGGTCTCGGTC; and Gapdh: 5 0 -GATGCCCCCATGTTTGTGAT; 3 0 -TTGTCATGGAT GACCTTGGC.
Real-time PCR was performed using the following temperature profile: denaturation: 95 1C for 15 min; cycling: melt 94 1C for 15 s; annealing: 53 1C for 8 s; extension: 72 1C for 8 s.
Melting-curve analysis was performed after each run and data were analyzed using Roche Lightcycler data analysis software (v3.5.28). DC T values for Aqp2, V2R, and Gapdh were determined using second-derivative analysis of the amplification curves. DC T for Gapdh was used to normalize data (subtracting Gapdh DC T from DC T for Aqp2 and V2R) and final results where expressed as a % compared with control.
cAMP measurements
Kidneys from 19-day-old wild-type and CKO mice were harvested and subsequently homogenized in 0.1 M HCl. Total cyclic was measured in the resulting lysates using an enzymatic immunoassay (Sigma, St Louis, MO, USA) according to the manufacturer's protocol. The assay is based on competition between unlabeled cAMP and peroxidase-labeled cAMP for a limited number of sites on an immobilized cAMP-specific antibody. The amount of peroxidase-labeled ligand bound by the antibody is inversely proportional to the concentration of unlabeled cAMP. Standard curves were generated for each experiment.
Western blot analysis
Western blotting was performed as previously described. 18 The primary antibodies used included rabbit anti-PC2 polyclonal antibody 96525, 33 rabbit anti-PC1 polyclonal antibody 96521, rabbit anti-p21 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-p27 polyclonal antibody (Santa Cruz Biotechnology), and mouse anti-PC1 monoclonal antibody (7e12; a kind gift from Dr C Ward). The secondary antibody used for western blotting was goat anti-rabbit IgG-horseradish peroxidase or goat-anti-mouse IgG-horseradish peroxidase, 1:10 000 dilution (Amersham Biosciences, Pittsburgh, PA, USA).
TUNEL staining of formalin-fixed, paraffin-embedded tissue sections was performed using the Apoptag, Peroxidase In Situ apoptosis Detection kit (Chemicon, CA, USA) according to the manufacturer's protocol, and light-microscopic images were taken with a Leica DMLS microscope (Leica Microsystems GmbH, Nussloch, Germany) equipped with a Kodak DC290 camera (Kodak, Rochester, NY, USA).
Digital analysis of cyst size
Paraffin sections were pretreated as described and subsequently co-stained with DBA and LTA. Epifluorescent images were taken at a total magnification of Â 100. At least four different fields per section were photographed, and cyst number and cyst area were measured using Image Pro Plus v5 software (Media Cybernetics, MD, USA), and numerical data were subsequently processed in Microsoft Excel.
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